We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
The Discovery of a Specific CKIP-1 Ligand for the Potential Treatment of Disuse Osteoporosis.
- Authors
Wei, Yange; Wu, Bo; Liu, Mingqiu; Cui, Chun-Ping
- Abstract
Bone homeostasis relies on the delicate balance between osteoblast-mediated bone formation and osteoclast-mediated bone resorption. The casein kinase 2 interacting protein-1 (CKIP-1), a specific CK2α subunit-interacting protein, has been documented as one of the crucial negative regulators of bone formation. CKIP-1 siRNA therapy has constraints that limit its use in clinical applications. Therefore, it is necessary to explore effective targeting strategies for CKIP-1. In this study, we observed an upregulation of CKIP-1 protein expression in the microgravity environment, while its ubiquitination levels decreased. We further investigated the interaction between CKIP-1 and VHL and found that VHL enhanced CKIP-1 degradation through the ubiquitylation–proteasome system (UPS). Additionally, we discovered a small molecule ligand, named C77, through DNA-encoded library (DEL) screening, which binds to CKIP-1 both in vivo and in vitro, as confirmed by Surface Plasmon Resonance (SPR) and the Cellular Thermal shift assay (CETSA), respectively. Our findings demonstrated the potential of VHL and C77 as guiding factors in the development of CKIP-1-based Proteolysis-Targeting Chimeras (PROTACs), which could be future therapeutic interventions in disuse osteoporosis.
- Subjects
SURFACE plasmon resonance; BONE growth; SMALL molecules; BONE resorption; PROTEIN expression
- Publication
International Journal of Molecular Sciences, 2024, Vol 25, Issue 16, p8870
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms25168870